David-alexandre C Gros - Net Worth and Insider Trading
David-alexandre C Gros Net Worth
The estimated net worth of David-alexandre C Gros is at least $310,160 dollars as of 2024-11-05. David-alexandre C Gros is the SVP, Chief Business Officer of Alnylam Pharmaceuticals Inc and owns about 1,000 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $265,970. David-alexandre C Gros is also the CEO of Eledon Pharmaceuticals Inc and owns about 9,000 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $44,190. Details can be seen in David-alexandre C Gros's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David-alexandre C Gros has not made any transactions after 2021-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David-alexandre C Gros
David-alexandre C Gros Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David-alexandre C Gros owns 3 companies in total, including Eledon Pharmaceuticals Inc (ELDN) , Neurocrine Biosciences Inc (NBIX) , and Alnylam Pharmaceuticals Inc (ALNY) .
Click here to see the complete history of David-alexandre C Gros’s form 4 insider trades.
Insider Ownership Summary of David-alexandre C Gros
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2021-12-20 | director & Chief Executive Officer |
| NBIX | Neurocrine Biosciences Inc | 2017-01-09 | President & COO |
| ALNY | Alnylam Pharmaceuticals Inc | 2016-02-22 | SVP & Chief Business Officer |
David-alexandre C Gros Latest Holdings Summary
David-alexandre C Gros currently owns a total of 2 stocks. Among these stocks, David-alexandre C Gros owns 1,000 shares of Alnylam Pharmaceuticals Inc (ALNY) as of February 22, 2016, with a value of $265,970 and a weighting of 85.75%. David-alexandre C Gros also owns 9,000 shares of Eledon Pharmaceuticals Inc (ELDN) as of December 20, 2021, with a value of $44,190 and a weighting of 14.25%.
Latest Holdings of David-alexandre C Gros
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2016-02-22 | 1,000 | 265.97 | 265,970 |
| ELDN | Eledon Pharmaceuticals Inc | 2021-12-20 | 9,000 | 4.91 | 44,190 |
Holding Weightings of David-alexandre C Gros
David-alexandre C Gros Form 4 Trading Tracker
According to the SEC Form 4 filings, David-alexandre C Gros has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the acquisition of 1,000 shares on February 22, 2016, which cost David-alexandre C Gros around $62,750.
According to the SEC Form 4 filings, David-alexandre C Gros has made a total of 2 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Eledon Pharmaceuticals Inc is the acquisition of 2,000 shares on December 20, 2021, which cost David-alexandre C Gros around $8,960.
Insider Trading History of David-alexandre C Gros
- 1
David-alexandre C Gros Trading Performance
GuruFocus tracks the stock performance after each of David-alexandre C Gros's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David-alexandre C Gros is -14.94%. GuruFocus also compares David-alexandre C Gros's trading performance to market benchmark return within the same time period. The performance of stocks bought by David-alexandre C Gros within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David-alexandre C Gros's insider trading performs compared to the benchmark.
Performance of David-alexandre C Gros
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.75 | | | | | |
| Relative Return to S&P 500(%) | -1.8 | | | | | |
David-alexandre C Gros Ownership Network
Ownership Network List of David-alexandre C Gros
Ownership Network Relation of David-alexandre C Gros
David-alexandre C Gros Owned Company Details
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
David-alexandre C Gros is the director & Chief Executive Officer of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and CHIEF FINANCIAL OFFICER Paul Sean Little .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
David-alexandre C Gros Mailing Address
Above is the net worth, insider trading, and ownership report for David-alexandre C Gros. You might contact David-alexandre C Gros via mailing address: 220 Marlborough Street, #6, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
